Navigation Links
Pacific Shore Holdings, Inc. Receives Symbol Change Approval From FINRA
Date:2/14/2011

LOS ANGELES, Feb 14, 2011 /PRNewswire/ -- Pacific Shore Holdings, Inc. (previously Green Shores, Inc.), a Delaware corporation, announced today that management has received approval from the Financial Industry Regulatory Authority ("FINRA") for the change of its symbol to "PSHR.PK" from "GSHR.PK". "We are excited about the symbol change, as it takes us one step closer to completion of our planned entrance into the Public Markets. "Once we enter the Public Marketplace, we believe that we will be in position to attract significant capital infusions from a multitude of Market players," states Pacific Shore Holdings, Inc. Chief Financial Officer Ronald J. Tchorzewski.

Building on its corporate governance, Pacific Shore Holdings, Inc. also announced today that it has appointed Matthew A. Mills as Chairman of the Board, President and Chief Executive Officer of the Company replacing Dr. David E. Toomey who will remain as a Director of the Company as well as Executive Vice President. In addition, Mr. Mills announced the appointments of Ronald J. Tchorzewski as Chief Financial Officer and Director, Jennifer Mills as Corporate Secretary and Director and Dr. Allan Kurtz as a Director. "I am pleased with these appointments as each individual brings with them valuable experience and expertise to help take our Company to the next level. Our multiple brands and products have shown a very positive response from consumers around the world during our test marketing programs. I believe we will now be poised to secure the financial resources necessary to begin aggressive product marketing campaigns nationally and internationally to successfully expand our operations," states President and Chief Executive Officer Matthew Mills.

About Pacific Shore Holdings, Inc.: Pacific Shore Holdings, Inc. is a Delaware corporation whose dormant common stock has a trading symbol on the Pink Sheets of "PSHR.PK" which was previously "GSHR.PK". For more information, contact Pacific Shore Holdings, Inc. at info@pac-sh.com or (818) 998-0996.

Forward-Looking Statements: Certain statements in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) and accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events.


'/>"/>
SOURCE Pacific Shore Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen
2. Asia Pacific Flexible Alternating Current Transmission Equipment Markets
3. BioProcess International Launches Monthly Asia-Pacific eNewsletter
4. Sundia Named Deloitte Technology Fast 500 Asia Pacific for 2nd Consecutive Year
5. OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst & Youngs Entrepreneur Of The Year(R) in the Health Sciences Category
6. Hugh Tilson Receives Leadership Award at Pacific Drug Safety Summit
7. Pacific Biometrics Completes $4 Million Debt Financing
8. Pacific Health Research Institute Awarded $2.8 Million in Research Funding
9. Pacific Health Research Institute Awarded $2.8 Million in Research Funding
10. PacificGMP and USC to Collaborate on Recombinant Protein Development and Manufacturing for Phase 1 Clinical Trial
11. Avantium to Deliver Flowrence System to Pacific Northwest National Laboratory (PNNL), USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
Breaking Biology News(10 mins):